Literature DB >> 10071721

Thioperamide, a histamine H3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats.

E Itoh1, M Fujimiya, A Inui.   

Abstract

BACKGROUND: Whether or not peptide YY (PYY)-induced hyperphagia is modified by the histaminergic system in the brain is not yet known.
METHODS: We investigated the effect on feeding of intracerebroventricular (ICV) administration of a specific histamine H3 receptor antagonist prior to ICV administration of PYY in rats.
RESULTS: PYY (1, 3, and 10 micrograms/10 microL) strongly induced feeding behavior in a dose-dependent manner in sated rats. The 4-hour food intake induced by 3 micrograms/10 microL of PYY was equal to that induced by a 16-hour fast. The ICV administration of thioperamide (40.8, 122.4, and 408.5 micrograms/10 microL) did not suppress the 4-hour food intake induced by 16-hour fasting; however, thioperamide produced dose-dependent and strong inhibition of hyperphagia induced by a 3-microgram dose of PYY.
CONCLUSIONS: These results suggest that the effect of PYY on appetite is different than that induced by fasting and may involve a histaminergic mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10071721     DOI: 10.1016/s0006-3223(98)00044-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  3 in total

1.  Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus.

Authors:  Ryo Yoshimoto; Yasuhisa Miyamoto; Ken Shimamura; Akane Ishihara; Kazuhiko Takahashi; Hidehito Kotani; Airu S Chen; Howard Y Chen; Douglas J Macneil; Akio Kanatani; Shigeru Tokita
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

2.  Effects of neonatal methamphetamine and thioperamide exposure on spatial memory retention and circadian activity later in life.

Authors:  Emily Eastwood; Charles N Allen; Jacob Raber
Journal:  Behav Brain Res       Date:  2012-02-11       Impact factor: 3.332

3.  Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist.

Authors:  A J Barbier; C Berridge; C Dugovic; A D Laposky; S J Wilson; J Boggs; L Aluisio; B Lord; C Mazur; C M Pudiak; X Langlois; W Xiao; R Apodaca; N I Carruthers; T W Lovenberg
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.